Skip to main content

Table 2 Baseline characteristics of patients with stroke according to loop diuretic use after propensity score matching

From: Association between diuretic use and the risk of vertebral fracture after stroke: a population-based retrospective cohort study

 

Loop diuretic use

p value

Yes (n = 2364)

No (n = 2364)

n

%

n

%

Age (years)

0.645

 < 60

398

16.8

375

15.9

 

 60–79

1306

55.3

1314

55.6

 ≥ 80

660

27.9

675

28.5

Gender

0.792

 Male

1344

56.9

1335

56.5

 

 Female

1020

43.1

1029

43.5

Income level (NTD)

0.215

 Financially dependent

822

34.8

821

34.7

 

 1–19,999

1283

54.3

1323

56.0

 20,000–39,999

188

7.9

167

7.1

  ≥ 40,000

71

3.0

53

2.2

Urbanization level

0.943

 1 (Most urbanized)

542

22.9

541

22.9

 

 2

604

25.6

612

25.9

 3

403

17.1

402

17.0

 4

469

19.8

449

19.0

 5 (Least urbanized)

346

14.6

360

15.2

Stroke type

0.524

 Ischemic

1431

60.5

1467

62.0

 

 Hemorrhagic

373

15.8

380

16.1

 TIA

321

13.6

298

12.6

 Others

239

10.1

219

9.3

Charlson comorbidity index

0.415

 1–2

1073

45.4

1110

47.0

 

 3–4

774

32.7

733

31.0

  ≥ 5

517

21.9

521

22.0

Hypertension

1840

77.8

1854

78.4

0.622

Diabetes mellitus

970

41.0

976

41.3

0.859

COPD

646

27.3

657

27.8

0.720

Congestive heart failure

459

19.4

427

18.1

0.233

Chronic liver disease

299

12.7

288

12.2

0.628

Chronic kidney disease

379

16.0

355

15.0

0.335

Osteoporosis

133

5.6

133

5.6

1.000

Malignancy

190

8.0

170

7.2

0.273

Dementia

169

7.1

154

6.5

0.387

Depression

139

5.9

128

5.4

0.488

Epilepsy

46

1.9

39

1.6

0.444

Parkinsonism

121

5.1

122

5.2

0.947

  1. A χ2 test was used to compare the differences between the two groups
  2. Abbreviations: NTD New Taiwan dollars, COPD chronic obstructive pulmonary disease, TIA transient ischemic attack